Compound Q&A
What is the market or research trend for Exendin (9-39) (CAS: 133514-43-9)?
Answer
Exendin (9-39) (CAS: 133514-43-9) continues to be a subject of research in diabetes treatment, particularly in the development of GLP-1 receptor agonists. Market trends indicate a growing interest in this area due to its potential for reducing both type 1 and type 2 diabetes complications. However, there is ongoing exploration of other peptides and compounds that could offer comparable or improved therapeutic benefits.
About
CAS No
133514-43-9
English Name
Exendin (9-39)
Molecular Formula
C149H234N40O47S
Molecular Weight
3369.8 g/mol
SMILES
CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CO)C(=O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)N
InChIKey
WSEVKKHALHSUMB-MVNVRWBSSA-N
Last Updated: 2025-10-20 12:31
